Table 1.
Characteristics of the study sample.
| Variables | n (%) |
|---|---|
| n | 154 |
| Female | 61 (39.6) |
| Of which have the menopause | 33 (54.1) |
| Age (y) (mean ± SD) | 52.27 ± 7.46 |
| Marital Status | |
| Single | 14 (9.1) |
| Married/domestic partnership | 116 (75.3) |
| Divorced/separated/widowed | 24 (15.6) |
| Employment | |
| Working | 115 (74.7) |
| Unemployed/retired/housewife | 39 (25.3) |
| Education Level | |
| University/post-university | 44 (28.6) |
| Secondary education | 61 (39.6) |
| Primary education | 41 (26.6) |
| None | 8 (5.2) |
| Currently smoking | 25 (16.1) |
| Alcohol ≥ 7 drinks/w | 26 (16.9) |
| Regular Physical Activity | |
| None | 66 (43.1) |
| Light | 53 (34.6) |
| Moderate | 25 (16.3) |
| Heavy | 9 (5.9) |
| T2DM | 33 (21.4) |
| High BP | 62 (40.3) |
| Concomitant drugs | |
| Hypoglycemic agents | |
| Any | 30 (19.6) |
| Oral hypoglycemic agents alone | 26 (16.9) |
| Insulin and oral hypoglycemic agents | 4 (2.6) |
| Antihypertensive Agents | |
| Any | 53 (34.4) |
| Diuretic | 17 (11.1) |
| β-Blocker | 8 (5.2) |
| Calcium-channel blockers | 9 (5.9) |
| ACE inhibitors/ARBs | 47 (30.7) |
| Lipid-Lowering Agents | |
| Any | 43 (28.1) |
| Statin alone | 27 (17.6) |
| Fibrate alone | 8 (5.2) |
| Statin and fibrate | 4 (2.6) |
| Antiplatelet agent | 7 (4.6) |
| Concomitant Drugs–Other | |
| Any | 82 (53.6) |
| Thyroid medications | 10 (6.5) |
| Depression/anxiety/insomnia | 26 (17.0) |
| Gout medications | 10 (6.5) |
Data are expressed as count (%), unless otherwise specified. SD = standard deviation; T2DM = type 2 diabetes mellitus; BP = blood pressure; ACE = angiotensin converting enzyme; ARBs = angiotensin II receptor blockers.